Cerebrolysin for acute ischaemic stroke — Cochrane review
Moderate-certainty evidence found no beneficial effect on all-cause death; non-death attrition evidence very uncertain.
What this study tells us
This study reviewed or combined evidence from multiple studies. It can show the overall direction of a field, but its conclusion still depends on the quality and relevance of the studies it included.
Adults with acute ischaemic stroke
n=Multiple trials; SAE analysis 1335
Moderate-certainty evidence found no beneficial effect on all-cause death; non-death attrition evidence very uncertain.
Heterogeneous peptide mixtures/trials; clinical outcome data limited; indication-specific.
Need help with terms such as randomized, placebo, endpoint or sample size? Open the glossary →
Key result
Moderate-certainty evidence found no beneficial effect on all-cause death; non-death attrition evidence very uncertain.